Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma

Acta Derm Venereol. 2021 Apr 12;101(4):adv00426. doi: 10.2340/00015555-3715.
No abstract available

Keywords: KIT inhibitor; KIT mutation; mucosal melanoma; penile melanoma.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Melanoma* / drug therapy
  • Melanoma* / genetics
  • Mutation
  • Proto-Oncogene Proteins c-kit / genetics

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit